Back
Delegates Premium Access

Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease

Session: Genetic mechanisms of cardiovascular risk
Topic: Lipid-Lowering Agents
Speaker: Assistant Professor L. Tschiderer (Innsbruck, AT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Lena Tschiderer

Medical University of Innsbruck, Innsbruck (Austria)
0 follower

4 more presentations in this session

Cardiorespiratory fitness, cardiovascular health, and other chronic diseases: a phenome-wide Mendelian randomization study

Speaker: Mrs E. Fornara (Rm, IT)

Access
Abstract
Slides
Like
Thumbnail

Genetic interleukin-6 receptor blockade, chronic disease risk and longevity

Speaker: Doctor S. Wissel (Wurzburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Polygenic prediction of cardiorespiratory fitness and relation to cardiovascular disease: the HUNT study

Speaker: Miss M. Klevjer (Trondheim, NO)

Access
Abstract
Slides
Like
Thumbnail

Homozygous familial hypercholesterolemia Evaluation and Survival study in Saudi Arabia (HESSA): genetic and molecular characteristics of the largest genetic cohort in the middle east

Speaker: Assistant Professor N. Kholaif (Riyadh, SA)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Genetic mechanisms of cardiovascular risk

Speakers: Assistant Professor L. Tschiderer, Mrs E. Fornara, Doctor S. Wissel, Miss M. Klevjer, Assistant Professor N. Kholaif
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources